North America Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024

List of Tables

The North America Ruminant Vaccines Market would witness market growth of 5.9% CAGR during the forecast period (2024-2031).

The US market dominated the North America Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,257.3 million by 2031. The Canada market is experiencing a CAGR of 8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7% during (2024 - 2031).

The ruminant vaccines market refers to the segment of the veterinary pharmaceutical industry that focuses on developing, manufacturing, distributing, and selling vaccines specifically designed for ruminant species. Ruminants are a group of mammals with a unique digestive system capable of digesting plant-based diets through rumination. Common ruminant species include cattle (both beef and dairy), sheep, goats, and certain species of deer.

The vaccines are crucial in preventing and controlling a wide range of infectious diseases affecting cattle, sheep, goats, and other ruminant species. These vaccines are utilized in various applications within livestock production systems to safeguard animal health, improve production efficiency, and reduce economic losses. For example, respiratory diseases are a significant concern in ruminant production systems, particularly in intensive or confined housing environments.

With the expansion of the red meat industry in Canada, there is a heightened need for disease prevention and control measures to safeguard the health and productivity of ruminant livestock. The Canadian government states that the country's red meat sector consists of pig, lamb mutton, goat, rabbit, horse, venison, bison, and beef & veal. In 2022, the red meat business had annual shipments of $24.72 billion. There were 1,040,200 sheep and lambs as of 2019. Most of Canada's sheep are produced in Ontario, Quebec, and Alberta (72%). Sheep and lamb farm cash receipts in 2019 totaled $189 million, or 0.3% of overall agricultural cash receipts. Thus, the rising meat industry in the region is driving the market's growth.

Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Boehringer Ingelheim International GmbH
Zoetis, Inc.
Merck & Co., Inc.
Bimeda, Inc.
Elanco Animal Health, Inc.
Virbac
Ceva Sante Animale
CZ Vaccines S.A.U. (Zendal Health S.A.)
Indian Immunologicals Ltd. (National Dairy Development Board)
Vaxxinova International BV (EW Group)

North America Ruminant Vaccines Market Report Segmentation

By Animal Type

Cattle
Sheep & Goats

By Vaccines Type

Modified/ Attenuated Live
Inactivated (Killed)
Others

By Route of Administration

Injectable
Intranasal

By Indication

Bovine Respiratory Diseases (BRD)
Diarrhea/ Scours
FMD
Clostridial Diseases
Leptospirosis
BVD Infection
Others

By Country

US
Canada
Mexico
Rest of North America

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1North America Ruminant Vaccines Market, by Animal Type
- 1.4.2North America Ruminant Vaccines Market, by Vaccines Type
- 1.4.3North America Ruminant Vaccines Market, by Route of Administration
- 1.4.4North America Ruminant Vaccines Market, by Indication
- 1.4.5North America Ruminant Vaccines Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Recent strategies deployed in Ruminant Vaccines Market

Chapter 5.North America Ruminant Vaccines Market by Animal Type

5.1North America Cattle Market by Country
5.2North America Sheep & Goats Market by Country

Chapter 6.North America Ruminant Vaccines Market by Vaccines Type

6.1North America Modified/ Attenuated Live Market by Country
6.2North America Inactivated (Killed) Market by Country
6.3North America Others Market by Country

Chapter 7.North America Ruminant Vaccines Market by Route of Administration

7.1North America Injectable Market by Country
7.2North America Intranasal Market by Country

Chapter 8.North America Ruminant Vaccines Market by Indication

8.1North America Bovine Respiratory Diseases (BRD) Market by Country
8.2North America Diarrhea/ Scours Market by Country
8.3North America FMD Market by Country
8.4North America Clostridial Diseases Market by Country
8.5North America Leptospirosis Market by Country
8.6North America BVD Infection Market by Country
8.7North America Others Market by Country

Chapter 9.North America Ruminant Vaccines Market by Country

9.1US Ruminant Vaccines Market
- 9.1.1US Ruminant Vaccines Market by Animal Type
- 9.1.2US Ruminant Vaccines Market by Vaccines Type
- 9.1.3US Ruminant Vaccines Market by Route of Administration
- 9.1.4US Ruminant Vaccines Market by Indication
9.2Canada Ruminant Vaccines Market
- 9.2.1Canada Ruminant Vaccines Market by Animal Type
- 9.2.2Canada Ruminant Vaccines Market by Vaccines Type
- 9.2.3Canada Ruminant Vaccines Market by Route of Administration
- 9.2.4Canada Ruminant Vaccines Market by Indication
9.3Mexico Ruminant Vaccines Market
- 9.3.1Mexico Ruminant Vaccines Market by Animal Type
- 9.3.2Mexico Ruminant Vaccines Market by Vaccines Type
- 9.3.3Mexico Ruminant Vaccines Market by Route of Administration
- 9.3.4Mexico Ruminant Vaccines Market by Indication
9.4Rest of North America Ruminant Vaccines Market
- 9.4.1Rest of North America Ruminant Vaccines Market by Animal Type
- 9.4.2Rest of North America Ruminant Vaccines Market by Vaccines Type
- 9.4.3Rest of North America Ruminant Vaccines Market by Route of Administration
- 9.4.4Rest of North America Ruminant Vaccines Market by Indication

Chapter 10.Company Profiles

10.1Boehringer Ingelheim International GmbH
- 10.1.1Company Overview
- 10.1.2Financial Analysis
- 10.1.3Regional & Segmental Analysis
- 10.1.4Research & Development Expenses
- 10.1.5Recent strategies and developments:
  - 10.1.5.1Partnerships, Collaborations, and Agreements:
  - 10.1.5.2Product Launches and Product Expansions:
  - 10.1.5.3Geographical Expansions:
- 10.1.6SWOT Analysis
10.2Zoetis, Inc.
- 10.2.1Company Overview
- 10.2.2Financial Analysis
- 10.2.3Regional Analysis
- 10.2.4Research & Development Expenses
- 10.2.5Recent strategies and developments:
  - 10.2.5.1Product Launches and Product Expansions:
- 10.2.6SWOT Analysis
10.3Merck & Co., Inc.
- 10.3.1Company Overview
- 10.3.2Financial Analysis
- 10.3.3Segmental and Regional Analysis
- 10.3.4Research & Development Expenses
- 10.3.5Recent strategies and developments:
  - 10.3.5.1Product Launches and Product Expansions:
- 10.3.6SWOT Analysis
10.4Bimeda, Inc.
- 10.4.1Company Overview
- 10.4.2SWOT Analysis
10.5Elanco Animal Health, Inc.
- 10.5.1Company Overview
- 10.5.2Financial Analysis
- 10.5.3Regional Analysis
- 10.5.4Research & Development Expenses
- 10.5.5SWOT Analysis
10.6Virbac
- 10.6.1Company Overview
- 10.6.2Financial Analysis
- 10.6.3Regional Analysis
- 10.6.4SWOT Analysis
10.7Ceva Sante Animale
- 10.7.1Company Overview
- 10.7.2Recent strategies and developments:
  - 10.7.2.1Acquisition and Mergers:
- 10.7.3SWOT Analysis
10.8CZ Vaccines S.A.U. (Zendal Health S.A.)
- 10.8.1Company Overview
- 10.8.2SWOT Analysis
10.9Indian Immunologicals Ltd. (National Dairy Development Board)
- 10.9.1Company Overview
- 10.9.2Financial Analysis
- 10.9.3Research & Development Expenses
- 10.9.4SWOT Analysis
10.10.Vaxxinova International BV (EW Group)
- 10.10.1Company Overview
- 10.10.2SWOT Analysis

LIST OF TABLES

TABLE 1North America Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 2North America Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 3North America Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 4North America Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 5North America Cattle Market by Country, 2020 - 2023, USD Million
TABLE 6North America Cattle Market by Country, 2024 - 2031, USD Million
TABLE 7North America Sheep & Goats Market by Country, 2020 - 2023, USD Million
TABLE 8North America Sheep & Goats Market by Country, 2024 - 2031, USD Million
TABLE 9North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 10North America Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 11North America Modified/ Attenuated Live Market by Country, 2020 - 2023, USD Million
TABLE 12North America Modified/ Attenuated Live Market by Country, 2024 - 2031, USD Million
TABLE 13North America Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
TABLE 14North America Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
TABLE 15North America Others Market by Country, 2020 - 2023, USD Million
TABLE 16North America Others Market by Country, 2024 - 2031, USD Million
TABLE 17North America Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 18North America Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 19North America Injectable Market by Country, 2020 - 2023, USD Million
TABLE 20North America Injectable Market by Country, 2024 - 2031, USD Million
TABLE 21North America Intranasal Market by Country, 2020 - 2023, USD Million
TABLE 22North America Intranasal Market by Country, 2024 - 2031, USD Million
TABLE 23North America Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 24North America Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 25North America Bovine Respiratory Diseases (BRD) Market by Country, 2020 - 2023, USD Million
TABLE 26North America Bovine Respiratory Diseases (BRD) Market by Country, 2024 - 2031, USD Million
TABLE 27North America Diarrhea/ Scours Market by Country, 2020 - 2023, USD Million
TABLE 28North America Diarrhea/ Scours Market by Country, 2024 - 2031, USD Million
TABLE 29North America FMD Market by Country, 2020 - 2023, USD Million
TABLE 30North America FMD Market by Country, 2024 - 2031, USD Million
TABLE 31North America Clostridial Diseases Market by Country, 2020 - 2023, USD Million
TABLE 32North America Clostridial Diseases Market by Country, 2024 - 2031, USD Million
TABLE 33North America Leptospirosis Market by Country, 2020 - 2023, USD Million
TABLE 34North America Leptospirosis Market by Country, 2024 - 2031, USD Million
TABLE 35North America BVD Infection Market by Country, 2020 - 2023, USD Million
TABLE 36North America BVD Infection Market by Country, 2024 - 2031, USD Million
TABLE 37North America Others Market by Country, 2020 - 2023, USD Million
TABLE 38North America Others Market by Country, 2024 - 2031, USD Million
TABLE 39North America Ruminant Vaccines Market by Country, 2020 - 2023, USD Million
TABLE 40North America Ruminant Vaccines Market by Country, 2024 - 2031, USD Million
TABLE 41US Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 42US Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 43US Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 44US Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 45US Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 46US Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 47US Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 48US Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 49US Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 50US Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 51Canada Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 52Canada Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 53Canada Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 54Canada Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 55Canada Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 56Canada Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 57Canada Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 58Canada Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 59Canada Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 60Canada Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 61Mexico Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 62Mexico Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 63Mexico Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 64Mexico Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 65Mexico Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 66Mexico Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 67Mexico Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 68Mexico Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 69Mexico Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 70Mexico Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 71Rest of North America Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 72Rest of North America Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 73Rest of North America Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 74Rest of North America Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 75Rest of North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 76Rest of North America Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 77Rest of North America Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 78Rest of North America Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 79Rest of North America Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 80Rest of North America Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 81Key Information - Boehringer Ingelheim International GmbH
TABLE 82Key Information - Zoetis, Inc.
TABLE 83Key Information - Merck & Co., Inc.
TABLE 84Key Information - Bimeda, Inc.
TABLE 85Key information - Elanco Animal Health, Inc.
TABLE 86Key Information - Virbac
TABLE 87Key Information - Ceva SantE Animale
TABLE 88Key Information - CZ Vaccines S.A.U.
TABLE 89Key Information - Indian Immunologicals Ltd.
TABLE 90Key Information - Vaxxinova International BV

North America Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents